Cargando…

Yi Shen Juan Bi Pill Ameliorates Bone Loss and Destruction Induced by Arthritis Through Modulating the Balance of Cytokines Released by Different Subpopulations of T Cells

The Yi Shen Juan Bi Pill (YSJB), a traditional Chinese compound herbal drug, has been used as an anti-rheumatic drug in clinical practice. Cartilage and bone destruction of inflamed joints is the hallmark of rheumatoid arthritis (RA). Our previous study suggested that YSJB had a protective effect on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hongyan, Xu, Huihui, Zuo, Zhengyun, Wang, Gui, Liu, Meijie, Guo, Minghui, Xiao, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880890/ https://www.ncbi.nlm.nih.gov/pubmed/29636683 http://dx.doi.org/10.3389/fphar.2018.00262

Ejemplares similares

Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling
por: Xu, Huihui, et al.
Publicado: (2022)

The Protective Effect of Yi Shen Juan Bi Pill in Arthritic Rats with Castration-Induced Kidney Deficiency
por: Zhao, Hongyan, et al.
Publicado: (2012)

Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment via the JAK2/STAT3 Signaling Pathway in Vitro
por: Xia, Ya, et al.
Publicado: (2021)

Immunomodulatory activity of a Chinese herbal drug Yi Shen Juan Bi in adjuvant arthritis
por: Perera, Pathirage Kamal, et al.
Publicado: (2010)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill(®) via ameliorate of multiple mitochondrial dysfunctions
por: Chen, Jing Rui, et al.
Publicado: (2015)

Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats
por: Lv, Shichao, et al.
Publicado: (2016)

QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy
por: Lv, Shichao, et al.
Publicado: (2020)

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
por: Lv, Shichao, et al.
Publicado: (2022)

QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats
por: Lv, Shichao, et al.
Publicado: (2021)

QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats
por: Tang, Dong-Xin, et al.
Publicado: (2013)

Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial
por: Shang, Hongcai, et al.
Publicado: (2013)

Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation
por: Lv, Shichao, et al.
Publicado: (2015)

Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice
por: Ruan, Guoran, et al.
Publicado: (2018)

QiShenYiQi pill attenuates atherosclerosis by promoting regulatory T cells, inhibiting T helper 17 cells and accelerating cholesterol excretion
por: Peng, Li, et al.
Publicado: (2017)

The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury
por: Cui, Yuan-Chen, et al.
Publicado: (2018)

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
por: Ding, Congyang, et al.
Publicado: (2022)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2018)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

QiShenYiQi Pills, a Compound Chinese Medicine, Prevented Cisplatin Induced Acute Kidney Injury via Regulating Mitochondrial Function
por: Zhou, Li, et al.
Publicado: (2017)

QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway
por: Lv, Shichao, et al.
Publicado: (2021)

San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
por: Su, Xiuhai, et al.
Publicado: (2022)

Yi Shen An, a Chinese traditional prescription, ameliorates membranous glomerulonephritis induced by cationic bovine serum albumin in rats
por: Zhao, Yun-Li, et al.
Publicado: (2022)

Yi-Shen-Hua-Shi granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes
por: Liang, Mingzhu, et al.
Publicado: (2022)

QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway
por: Anwaier, Gulinigaer, et al.
Publicado: (2022)

Qi-Shen-Yi-Qi Dripping Pills Promote Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells by Regulating MicroRNA-223-3p Expression
por: Dai, Guo-Hua, et al.
Publicado: (2016)

QiShenYiQi Pills Attenuates Ischemia/Reperfusion-Induced Cardiac Microvascular Hyperpermeability Implicating Src/Caveolin-1 and RhoA/ROCK/MLC Signaling
por: Pan, Chun-Shui, et al.
Publicado: (2021)

QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin
por: Zhou, Zhanmei, et al.
Publicado: (2016)

Jian-Pi-Yi-Shen Formula Ameliorates Oxidative Stress, Inflammation, and Apoptosis by Activating the Nrf2 Signaling in 5/6 Nephrectomized Rats
por: Zhou, Fanyuan, et al.
Publicado: (2021)

QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode
por: Chen, Yuan-Yuan, et al.
Publicado: (2015)

Pharmaceutical and pharmacological studies of Shen Ma Yi Zhi granule for prevention of vascular dementia: A review
por: Chang, Su-rui, et al.
Publicado: (2022)

Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis
por: Feng, MinChao, et al.
Publicado: (2023)

A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease
por: Zhou, Xue-Feng, et al.
Publicado: (2021)

Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
por: Wang, Yule, et al.
Publicado: (2021)

Jian-Pi-Yi-Shen decoction inhibits mitochondria-dependent granulosa cell apoptosis in a rat model of POF
por: Jiang, Xiao-Lin, et al.
Publicado: (2022)

Protective effects and regulatory mechanisms of Shen-shuai-yi recipe on renal fibrosis in unilateral ureteral obstruction-induced mice
por: Lin, Ping-lan, et al.
Publicado: (2023)

San-Huang-Yi-Shen Capsule Ameliorates Diabetic Kidney Disease through Inducing PINK1/Parkin-Mediated Mitophagy and Inhibiting the Activation of NLRP3 Signaling Pathway
por: Li, Hanzhou, et al.
Publicado: (2022)

A Chinese herbal decoction, Jian-Pi-Yi-Shen, regulates the expressions of erythropoietin and pro-inflammatory cytokines in cultured cells
por: Chen, Jianping, et al.
Publicado: (2018)

A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi
por: Yu, Jiahui, et al.
Publicado: (2017)

QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
por: Ye, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hjlpf82prd9hh7b5ef31l5o3ie